Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ICE Bioscience is a specialized contract research organization (CRO) based in Beijing, focusing on drug discovery and preclinical pharmacology. The company is widely recognized for its expertise in high-value and technically challenging targets, including ion channels, GPCRs, kinases, and transporters. They provide a comprehensive range of services such as high-throughput screening, electrophysiology, and safety pharmacology, including hERG testing for cardiac safety. By integrating advanced technologies like automated patch clamping and FLIPR, ICE Bioscience supports global pharmaceutical and biotechnology companies in accelerating their lead optimization and candidate selection processes. Their service portfolio also extends to ADME, PK/PD, and in vivo pharmacology across various therapeutic areas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aisiyipu Technology.